GH-releasing peptide-2 administration prevents liver inflammatory response in endotoxemia

American Journal of Physiology - Endocrinology and Metabolism

Volumn 294, Issue 1, 2008, Pages

  Granado, Miriam ^a   Martín, Ana Isabel ^a   López Menduiña, María ^a   López Calderón, Asunción ^a   Villanúa, M Angeles ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Growth hormone releasing peptide 2; Insulin like growth factor I; Nitrites nitrates; Transaminases; Tumor necrosis factor

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GROWTH HORMONE SECRETAGOGUE RECEPTOR; LIPOPOLYSACCHARIDE; NITRATE; NITRITE; PRALMORELIN; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; COCULTURE; DIET RESTRICTION; ENDOTOXEMIA; FOOD INTAKE; HEPATITIS; LIVER CELL CULTURE; LIVER INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ALANINE TRANSAMINASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; ASPARTATE AMINOTRANSFERASES; CELLS, CULTURED; COCULTURE TECHNIQUES; ENDOTOXEMIA; HEPATITIS; HEPATOCYTES; INSULIN-LIKE GROWTH FACTOR I; LIPOPOLYSACCHARIDES; MALE; NITRATES; NITRIC OXIDE; NITRITES; OLIGOPEPTIDES; RATS; RATS, WISTAR; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 38349064852     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00308.2007     Document Type: Article

References (37)

1. Arthur MJ, Kowalski-Saunders P, Wright R. Effect of endotoxin on release of reactive oxygen intermediates by rat hepatic macrophages. Gastroenterology 95: 1588-1594, 1988.
2. Bar T, Stahlberg A, Muszta A, Kubista M. Kinetic outlier detection (KOD) in real-time PCR. Nucleic Acids Res 31: e105, 2003.
3. Bauer I, Al Sarraj J, Vinson C, Larsen R, Thiel G. Interleukin-1β and tetradecanoylphorbol acetate-induced biosynthesis of tumor necrosis factor α in human hepatoma cells involves the transcription factors ATF2 and c-Jun and stress-activated protein kinases. J Cell Biochem 100: 242-255, 2007.
4. Chang L, Du JB, Gao LR, Pang YZ, Tang CS. Effect of ghrelin on septic shock in rats. Acta Pharmacol Sin 24: 45-49, 2003.
5. Cobb JP, Danner RL. Nitric oxide and septic shock. JAMA 275: 1192-1196, 1996.
6. Czaja MJ, Flanders KC, Biempica L, Klein C, Zern MA, Weiner FR. Expression of tumor necrosis factor-α and transforming growth factor-β1 in acute liver injury. Growth Factors 1: 219-226, 1989.
7. Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem 192: 245-261, 1990.
8. Dehoux MJM, van Beneden RP, Fernández-Celemín L, Lause PL, Thissen JPM. Induction of MafBx and Murf ubiquitin ligase mRNAs in rat skeletal muscle after LPS injection. FEBS Lett 544: 214-217, 2003.
9. Dixit VD, Schaffer EM, Pyle RS, Collins GD, Sakthivel SK, Palaniappan R, Lillard JW, Taub DD. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 114: 57-66, 2004.
10. Fan J, Molina PE, Gelato MC, Lang CH. Differential tissue regulation of insulin-like growth factor-I content and binding proteins after endotoxin. Endocrinology 134: 1685-1692, 1994.
11. Filigheddu N, Gnocchi VF, Coscia M, Cappelli M, Porporato PE, Taulli R, Traini S, Baldanzi G, Chianale F, Cutrupi S, Arnoletti E, Ghè C, Fubini A, Surico N, Sinigalia F, Ponzetto C, Muccioli G, Crepaldi T, Graziani A. Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells. Mol Biol Cell 18: 986-994, 2007.
12. Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, Bhattacharya S, Carpenter R, Grossman AB, Korbonits M. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 87: 2988-2991, 2002.
13. Gonzalez-Rey E, Chorny A, Delgado M. Therapeutic action of ghrelin in a mouse model of colitis. Gastroenterology 130: 1707-1720, 2006.
14. Goto T, Takeuchi S, Miura K, Ohshima S, Mikami K, Yoneyama K, Sato M, Shibuya T, Watanabe D, Kataoka E, Segawa D, Endo A, Sato W, Yoshino R, Watanabe S. Suramin prevents fulminant hepatic failure resulting in reduction of lethality through the suppression of NF-kappaB activity. Cytokine 33: 28-35, 2006.
15. Granado M, Martín AI, Priego T, Villanúa MA, López-Calderón A. Inactivation of Kupffer cells by gadolinium administration prevents lipopolysaccharide-induced decrease in liver insulin-like growth factor-I and IGF-binding protein-3 gene expression. J Endocrinol 188: 503-511, 2006.
16. Granado M, Priego T, Martín AI, Vara E, López- Calderón A, Villanúa MA. Anti-tumor necrosis factor agent PEG-sTNFRI improves the growth hormone/insulin-like growth factor-I system in adjuvant-induced arthritic rats. Eur J Pharmacol 536: 204-210, 2006.
17. Granado M, Priego T, Martín AI, Villanúa MA, López-Calderón A. Anti-inflammatory effect of ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats. Am J Physiol Endocrinol Metab 288: E486-E492, 2005.
18. Granado M, Priego T, Martín AI, Villanúa MA, López-Calderón A. Ghrelin receptor agonist GHRP-2 prevents arthritis-induced increase in E3 ubiquitin-ligating enzymes MuRF1 and MAFbx gene expression in skeletal muscle. Am J Physiol Endocrinol Metab 289: E1007-E1014, 2005.
19. Granata R, Settanni F, Biancone L, Trovato L, Nano R, Bertuzzi F, Destefanis S, Annunziata M, Martinetti M, Catapano F, Ghe C, Isgaard J, Papotti M, Ghigo E, Muccioli G. Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3′,5′-cyclic adenosine monophosphate/ protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-kinase/Akt signaling. Endocrinology 148: 512-529, 2007.
20. Griffon B, Cillard J, Chevanne M, Morel I, Cillard P, Sergent O. Macrophage-induced inhibition of nitric oxide production in primary rat hepatocyte cultures via prostaglandin E2 release. Hepatology 28: 1300-1308, 1998.
21. Gui SY, Wei W, Wang H, Wu L, Sun WY, Wu CY. Protective effect of fufanghuangqiduogan against acute liver injury in mice. World J Gastroenterol 21: 2984-2989, 2005.
22. Guler R, Olleros ML, Vesin D, Parapanov R, Vesin C, Kantengwa S, Rubbia-Brandt L, Mensi N, Angelillo-Scherrer A, Martinez-Soria E, Tacchini-Cottier F, Garcia I. Inhibition of inducible nitric oxide synthase protects against liver injury induced by mycobacterial infection and endotoxins. J Hepatol 41: 773-781, 2004.
23. Hanada T, Toshinai K, Kajimura N, Nara-Ashizawa N, Tsukada T, Hayashi Y, Osuye K, Kangawa K, Matsukura S, Nakazato M. Anticachectic effect of ghrelin in nude mice bearing human melanoma cells. Biochem Biophys Res Commun 301: 275-279, 2003.
24. Hartung T, Wendel A. Endotoxin-inducible cytotoxicity in liver cell cultures. Biochem Pharmacol 42: 1129-1135, 1991.
25. Hataya Y, Akamizu T, Hosoda H, Kanamoto N, Moriyama K, Kangawa K, Takaya K, Nakao K. Alterations of plasma ghrelin levels in rats with lipopolysaccharide-induced wasting syndrome and effects of ghrelin treatment on the syndrome. Endocrinology 144: 5365-5371, 2003.
26. Hoebe KH, Witkamp RF, Fink-Gremmels J, Van Miert AS, Monshouwer M. Direct cell-to-cell contact between Kupffer cells and hepatocytes augments endotoxin-induced hepatic injury. Am J Physiol Gastrointest Liver Physiol 280: G720-G728, 2001.
27. Howard HD, Feighner SD, Cully DF, Liberator PA, Arena JP, Rosenblum CI, Hamelin MJ, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong SS, Chaung LY, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJ, Dean DC, Melillo DG, Patchett AA, Nargund R, Griffin PR, DeMartino JA, Gupta SK, Schaeffer JM, Smith RG, Van der Ploeg LH. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273: 974-977, 1996.
28. Inoue T, Horiai H, Aoki C, Kawamura I, Ota M, Mizuhara H, Tomoi M, Mutoh S. Insulin-like growth factor-I prevents lethal acute liver failure induced by D-galactosamine and lipopolysaccharide in rats. In Vivo 17: 293-299, 2003.
29. Jeschke MG, Rensing H, Klein D, Schubert T, Mautes AE, Bolder U, Croner RS. Insulin prevents liver damage and preserves liver function in lipopolysaccharide-induced endotoxemic rats. J Hepatol 42: 870-879, 2005.
30. Kamanaka Y, Kawabata A, Matsuya H, Taga C, Sekiguchi F, Kawao N. Effect of a potent iNOS inhibitor (ONO-1714) on acetaminophen-induced hepatotoxicity in the rat. Life Sci 74: 793-802, 2003.
31. Kamimura S, Tsukamoto H. Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease. Hepatology 22: 1304-1309, 1995.
32. Kasimay O, Iseri SO, Barlas A, Bangir D, Yegen C, Arbak S, Yegen BC. Ghrelin ameliorates pancreaticobiliary inflammation and associated remote organ injury in rats. Hepatol Res 36: 11-19, 2006.
33. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402: 656-660, 1999.
34. Kukan M, Vajdova K, Horecky J, Nagyova A, Mehendale HM, Trnovec T. Effects of blockade of Kupffer cells by gadolinium chloride on hepatobiliary function in cold ischemia-reperfusion injury of rat liver. Hepatology 26: 1250-1257, 1997.
35. Lang CH, Pollard V, Fan J, Traber L, Traber DL, Frost RA, Gelato MC, Prough DS. Acute alterations in growth hormone-insulin-like growth factor axis in humans injected with endotoxin. Am J Physiol Regul Integr Comp Physiol 273: R371-R378, 1997.
36. Liu MY, Cheng YJ, Chen CJ, Yang BC. Coexposure of lead- and lipopolysaccharide-induced liver injury in rats: involvement of nitric oxide-initiated oxidative stress and TNF-alpha. Shock 23: 360-364, 2005.
37. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001.